title: A general protease digestion procedure for optimal protein sequence coverage and post-translational modifications analysis of recombinant glycoproteins: application to the characterization of human lysyl oxidase-like 2 glycosylation.
abstract: Using recombinant DNA technology for expression of protein therapeutics is a maturing field of pharmaceutical research and development. As recombinant proteins are increasingly utilized as biotherapeutics, improved methodologies ensuring the characterization of post-translational modifications (PTMs) are needed. Typically, proteins prepared for PTM analysis are proteolytically digested and analyzed by mass spectrometry. To ensure full coverage of the PTMs on a given protein, one must obtain complete sequence coverage of the protein, which is often quite challenging. The objective of the research described here is to design a protocol that maximizes protein sequence coverage and enables detection of post-translational modifications, specifically N-linked glycosylation. To achieve this objective, a highly efficient proteolytic digest protocol using trypsin was designed by comparing the relative merits of denaturing agents (urea and Rapigest SF), reducing agents [dithiothreitol (DTT) and tris(2-carboxyethyl)phophine (TCEP)], and various concentrations of alkylating agent [iodoacetamide (IAM)]. After analysis of human apo-transferrin using various protease digestion protocols, ideal conditions were determined to contain 6 M urea for denaturation, 5 mM TCEP for reduction, 10 mM IAM for alkylation, and 10 mM DTT, to quench excess IAM before the addition of trypsin. This method was successfully applied to a novel recombinant protein, human lysyl oxidase-like 2. Furthermore, the glycosylation PTMs were readily detected at two glycosylation sites in the protein. These digestion conditions were specifically designed for PTM analysis of recombinant proteins and biotherapeutics, and the work described herein fills an unmet need in the growing field of biopharmaceutical analysis.
authors.affiliation: Department of Chemistry, University of Kansas, Lawrence, Kansas 66047, United States.
authors.forename: Kathryn R
authors.initials: KR
authors.lastname: Rebecchi
authors.forename: Eden P
authors.initials: EP
authors.lastname: Go
authors.forename: Li
authors.initials: L
authors.lastname: Xu
authors.forename: Carrie L
authors.initials: CL
authors.lastname: Woodin
authors.forename: Minae
authors.initials: M
authors.lastname: Mure
authors.forename: Heather
authors.initials: H
authors.lastname: Desaire
mesh_terms: D000594:Amino Acid Oxidoreductases / Q000032:analysis* / Q000737:chemistry / Q000378:metabolism; D001059:Apoproteins / Q000032:analysis* / Q000378:metabolism; D006031:Glycosylation; D006801:Humans; D013058:Mass Spectrometry; D010447:Peptide Hydrolases / Q000378:metabolism*; D011499:Protein Processing, Post-Translational; D059748:Proteolysis; D011994:Recombinant Proteins / Q000032:analysis / Q000737:chemistry / Q000378:metabolism; D020539:Sequence Analysis, Protein; D014168:Transferrin / Q000032:analysis* / Q000378:metabolism
chemical_list: D001059:Apoproteins; D011994:Recombinant Proteins; D014168:Transferrin; C028284:apotransferrin; D000594:Amino Acid Oxidoreductases; C119091:LOXL2 protein, human; D010447:Peptide Hydrolases